19 June // 2013, Eurogress Aachen Germanywww. biomedicasummit.com

PROGRAM

08:00 – 09:00 Registration

Opening session

Chair: Dipl. Ing. Michael Bayer, General manager, Chamber of Commerce, Aachen, Germany

09:00 – 09:15 Welcome Prof. Dr. Bernard Rentier, Chair of Biomedica Foundation

09:15 – 09:25 Opening Thomas Rachel, MdB, State secretary Federal Ministry of Education and Research, North-Rhine-Westphalia

09:25 – 10:05 Keynote presentation:Prof. Dr. Vasilis Ntziachristos, Director, Institute for biological and medical imaging (ibmi), Munich, Germany Optical and photoacoustic imaging for personalized medicine

Biopharmaceuticals & Nutraceuticals Ageing & In� ammation

Medical devicesImaging in oncology

BiomaterialsNovel biomaterials

Business SessionSubsession 1: Financing your company

MasterclassEntrepreneurship

Satellite conferenceEntry to the US Market for companies in Life Sciences

Chair: Prof. Dr. Sven Hendrix Chair department MRF, Biomed, Hasselt

University, Belgium

Co-chair: Prof. Dr. Theo Frans Meert Senior director External innovations

neurosciences, Janssen Pharmaceutical Companies, Johnson & Johnson, Beerse, Belgium

Chair: Mr. Michael Perkuhn Director of healthcare research, Philips Research

Laboratories, Aachen, Germany

Chair: Prof. Dr. med. Stefan JockenhoevelTissue Engineering &  Medical Textiles, Applied

Medical Engineering, Helmholtz Institute Aachen, RWTH Aachen University, Germany

Chair: Dr. Bernward Gartho� Cluster manager for biotechnology BIO.NRW, Germany

Chair: Dr. Henri TheunissenManaging director, Biomedbooster, Maastricht,

The Netherlands

10:10 – 10:35 Prof. Dr. Niels Hellings Vice-Director of the Biomedical Research Institute

(BIOMED), Hasselt University, Belgium The Ageing Immune System

Prof. Dr. Holger GruellPhilips Reserach, Eindhoven, The Netherlands, Biomedical engineering, Eindhoven university

of technology, The NetherlandsEmerging oncology applications in MR-HiFu

Dr. Andreas WaltherDeutsches Woll Institute, RWTH, Aachen, Germany

Bioinspired nanocellulose materials

10:10 – 10:25 Dr. Andy Stefan Roth

CEO, Qithera, General manager Dr. Roth Intellectual Property, Dusseldorf, Germany

QITHERA: A Business Angel Boost

10:10 – 11:00 Dr. Debbie Dumont

Investment manager , LRM, Hasselt,Belgium

10:00 – 10:10 Mr. Frank Malis CEO, IHK Aachen Mr. Nils Roeher

US Consulate General, Düsseldorf, GermanyWelcome

10:35 – 11:00 Dr. Björn Schumacher Group leader, CECAD Cluster of Excellence in

Ageing Research, University of Cologne, GermanyDNA Damage Responses in Ageing and Disease

Dr. Anke Henning Max Planck Institute, Tübingen, Institute for biomedical engineering, UZH/ETH Zürich,

SwitzerlandMR Spectroscopic Imaging in Oncology

Prof. Leo KoolenHead of Biomedical Engineering Department,

Maastricht University, The NetherlandsResearch and development of new biodegradable

materials and drug delivery systems within the context of BioMiMedics

10:30 – 10:55 Dr. Jean-Marie Stassen

Senior director of R&D, Thrombogenics, Leuven, BelgiumThrombogenics, From Bench to Market

10:10 – 10:30 Mr. Robert E. Anthony

Director of Entrepreneurial Services: Life Sciences, Akron Global Business Accelerator, Akron, Ohio, USA

How to enter the US market

10:30 – 10:50Mr. Rob Ngungu

Director of Regulatory A¢ airs and Product Development, Austen BioInnovation Institute in Akron (ABIA), Ohio, USA

Regulations for pharmaceutical and medical products

11:00 – 11:30 Co¢ ee break

11:30 – 12:10 Keynote presentation: Medical devicesProf. Dr. Peter Luijten Scienti£ c Director, Center for Translational Molecular Medicine (CTMM), The Netherlands,Professor of Functional Medical Imaging, University Medical Center Utrecht, The Netherlands.High Field MR Imaging in Oncology

Biopharmaceuticals & Nutraceuticals Ageing & In� ammation

Medical devicesImaging in oncology

BiomaterialsNovel biomaterials

Business Session Subsession 1: Financing your company

MasterclassIntellectual Property

Satellite conferenceEntry to the US Market for companies in Life Sciences

12:10 – 12:35 Dr. Bart Metselaar CEO, Enceladus BV Pharmaceuticals, Amsterdam, The Netherlands, Department of Targetet thera-peutics, University of Twente, The Netherlands

Targeted corticosteroid nanomedicines in the treatment of in� ammatory disease and cancer

Dr. Guido Mattias Kukuk Radiology Department,

University of Bonn, GermanyMR Imaging in Liver Oncology

Dr. Michael Rheinecker COE, Spintec Engineering Gmbh,

Aachen, GermanyNovel Silk Biomaterials for Medical Applications

12:15 – 12:30 Dr. Houtai Choumane

MBA, CEO, Artialis, Liège, BelgiumFunding startups: The business case of ARTIALIS

12:10 – 13:00Dr. Winand Habets

Life science Patents, Sittard, The Netherlands

12:10 – 12:35Pharmaceutical company (N.N.)

Experience with entry of the US market

12:35 – 13:00 Prof. Dr. A.M.W.J. Schols Scienti£ c Director, Nutrition and toxicology

research institute (NUTRIM), Maastricht University, The Netherlands

Activation of in� ammatory pathways in cronic obstructive pulmonary disease: accelerated ageing?

Dr. Dirk SmeetsCSO, Icometrix, Leuven, Belgium

Automated quanti� cation of images in oncology

Dr. Marc Hendriks Director R&D and Technology, DSM Biomedical,

Geleen, The NetherlandsQuo vadis? Biomaterials in Industries

(not yet con£ med)

12:30 – 12:45 Dr. Koen Dechering

CEO, TropIQ Health Sciences B.V.Founding TropIQ Health Sciences as a commercial malaria

research organisation in a not-for pro� t market

12:35 – 12:55Medical device company (N.N.)

Experience with entry of the US market

12:45 – 13:00 Dr. Wim BoogaertCEO, Instrumen NV

Spin O� � nancing , Investors , search for money and competencies 

12:55 – 13:00Discussions

13:00 – 14:00 Networking lunch break / poster awards jury visits (13:30 – 14:00)

Wednesday 19th June

19 June // 2013, Eurogress Aachen Germanywww. biomedicasummit.com

PROGRAM

Wednesday 19th June14:00 – 14:40 Keynote presentation: Biomaterials

Prof. Dr. Wolfram-Hubertus Zimmermann, Director, Department of Pharmacology, Heart Research Center, University Medical Center Göttingen, GermanyTissue Engineering for Drug Development and Organ Repair

Biopharmaceuticals & Nutraceuticals Ageing & nutritional interventions

Medical devicesHome-care & tele-medicine

BiomaterialsDrug delivery

Business SessionSubsession 2: Market approach and introduction

MasterclassBusiness Cases

Chair: Mr. Mike JanssenFounder Mixe BV, Nieuwegein, The Netherlands

14:40 – 15:05 Prof. Dr. Theo Frans Meert Senior director External innovations

neurosciences, Janssen Pharmaceutical Companies, Johnson & Johnson, Beerse, Belgium

Nutraceuticals and Ageing

Prof. Dr. Gernot MarxDirektor Anaesthesiology and Intensive Care Medicine, Academic hospital RWTH, Aachen,

GermanyRealization of intelligent health care networks

in the Aachen telemedicine center

Dr. Rob SteendamCTO, Innocore pharma BV

Biodegradable hydrophilic polymers for controlled parenteral delivery of proteins and peptides

14:40 – 15:00 Prof. Dr. Philippe Koninckx

CEO, EndoSat NV, Leuven, BelgiumThe AP-conditioner for pain and adhesions prevention

14:40 – 15:30 Mr. Pieter Goedhart, CEO and Dr. Hans Vink, CSO,

GlycoCheck BV, Maastricht, The Netherlands

Dr. Diederik Engbersen CEO, FABPulous BV, Maastricht, The Netherlands

15:05 – 15:30 Prof. Dr. Lex B. Verdijk Department of Movement Sciences, Faculty of Health, Medicine, and Life Sciences, Maastricht

University, The NetherlandsDietary strategies to augment muscle

mass in the elderly

Prof. Dr. J. G. S. Cleland Chair of Cardiology Departnment, Castle Hill

Hospital, University of Hull, Kingston-on-Hull, UKHome Monitoring of Heart Failuer Patients

Dr.-Ing Linda SchlewitCTO, FEG Textiltechnik mbH, Aachen, Germany

From Polymer to Optimal Textile Implants – A Challenge for the Engineer

15:00 – 15:20 Dr. Simon Dietz

Managing director, GfPS Gesellschaft für Produktions-hygiene und Sterilitätssicherung mbH, Aachen, Germany

Microbiological Challenges in the medical industry, Outsourcing possibilities

15:20 – 15:30 Mr. André Renard

Director, Labage SA, Liège, BelgiumIT management of variable and complex processes

in life sciences

15:30 – 16:00 Co¢ ee break

16:00 – 16:40 Keynote presentation: BiopharmaceuticalsDr. Laus Broersen Sr. Neuroscientist, Nutricia Advanced Medical Nutrition, Danone Research, Centre for Specialised Nutrition, Wageningen, The NetherlandsTargeting synaptic dysfunction in AD by administrating the speci� c nutrient combination Fortasyn Connect

Biopharmaceuticals & Nutraceuticals Ageing & nutritional interventions

Medical devicesHome-care & tele-medicine

BiomaterialsDrug delivery

Business SessionPivot Park, Oss, The Netherlands: presentations and pitches:

MasterclassFrom Science to Business

16:40 – 17:05 Dr. Jean-Claude Havaux CEO, ZenTech S.A., Liège, BelgiumMalnutrition in intensively ill ederly

Dipl. Ing. Christoph WesterteicherBusiness Director EU TeleHealth,

Philips Healthcare, Boeblingen, GermanyAdvancing Care Coordination and

TeleHealth in Europe

Prof. Dr. Christian Grand� llsDirector of the Interfacultary Research Center of Biomaterials (CEIB), University of Liege, Belgium

Hemoreactivity of polymeric carriers designed for drug delivery systems

16:40 – 17:15 Mr. Petrik Cuijpers

Managing director, Vivenics, Oss, The Netherlands

Dr. Koen DecheringCEO, TropIQ Health Sciences B.V., Oss, The Netherlands

Dr. Anja GarritsenCEO, Innatoss Laboratories BV, Oss, The Netherlands

16:40 – 17:30Dr. Kai U. Markus

CEO, Vimecon Gmbh, Herzogenrath, Germany

Prof. Dr. Paul Borm CEO, Nano4Imaging Gmbh, Aachen, Germany

17:05 – 17:30 Open for call Dr. Richard Houben General manager, Applied Biomedical Systems

B.V, Maastricht, The NetherlandsEarly Detection of Atrial Fibrillation

by MyDiagnostick

Dr. Cecilia SahlgrenDocent in Cell and Development Biology, (Åbo

Akademi University), Academy Research Fellow, Turku Centre for Biotechnology, Åbo Akademi

and Turku UniversityNanotechnology for targeted control of molecular

pathways in cancer and stem cell di� erentiation

17:15 – 19:00 Networking in business lounge

17:30 – 18:00 Poster presentations & awards

18:00 – 18:10 Closing

18:10 – 19:00 Reception